![Mathieu Simon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mathieu Simon
Direttore/Membro del Consiglio presso
IDORSIA LTD
Patrimonio netto: 543 345 $ in data 31/05/2026
Profilo
Mathieu Simon è presidente di Epsilen Bio SRL, presidente di Idorsia Ltd., amministratore indipendente di Asarina Pharma AB, amministratore indipendente di Vaximm AG, presidente di Idorsia Pharmaceuticals Ltd., amministratore delegato di Cellectis Therapeutics e amministratore indipendente di LNC Therapeutics SA. Fa parte del Consiglio di amministrazione di Lysogene SA, Asarina Pharma AB, Affimed NV, Affimed GmbH, Vaximm AG, Messier Maris & Associs SCA e LNC Therapeutics SA. Il Dr. Simon è stato precedentemente impiegato come EVP, Chief Operating & Medical Officer di Cellectis SA, Vicepresidente di Marketing & Medical Affairs di Wyeth Pharmaceuticals LLC, Group VP-Marketing & Clinical Affairs di Wyeth-Ayerst International, Inc., Senior Vice President-Global Operations di Pierre Fabre Mdicament SAS, Managing Director & Head-Global Pharma di Pierre Fabre SA e Chairman & Chief Executive Officer di Takara Bio Europe AB. È stato anche membro del consiglio di amministrazione di Alliance for Regenerative Medicine, Ectycell SASU e Farmindustria.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
IDORSIA LTD. 0,04% | 31/12/2024 | 95.061 ( 0,04% ) | 543 345 $ | 31/05/2026 |
Posizioni attive di Mathieu Simon
| Società | Posizione | Inizio |
|---|---|---|
| IDORSIA LTD | Direttore/Membro del Consiglio | 13/06/2024 |
Aileens Pharma Srl
 Aileens Pharma Srl Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on biotechnology | Presidente | - |
Idorsia Pharmaceuticals Ltd.
 Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceuticals | Presidente | 13/05/2020 |
Messier Maris & Associés SCA
 Messier Maris & Associés SCA Investment ManagersFinance Provides financial consulting and investment advisory services | Direttore/Membro del Consiglio | - |
Epsilen Bio Srl
 Epsilen Bio Srl Pharmaceuticals: MajorHealth Technology Develops therapies for genetic diseases | Presidente | 15/06/2020 |
Affimed GmbH
 Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Provides business and private economic services | Direttore/Membro del Consiglio | 01/01/2018 |
Precedenti posizioni note di Mathieu Simon
| Società | Posizione | Fine |
|---|---|---|
| AFFIMED N.V. | Direttore/Membro del Consiglio | 26/06/2024 |
| CELLECTIS S.A. | Direttore Tecnico/Scientifico/R&S | 14/03/2018 |
Cellectis Therapeutics | Amministratore Delegato | 01/02/2014 |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Mathieu Simon
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
34
Relazioni di 1° grado
22
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 22 |
|---|---|
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets infant pharmaceutical products | Health Technology |
Affimed NV
 Affimed NV Pharmaceuticals: MajorHealth Technology Discovers and develops antibody-based therapeutic drugs | Health Technology |
Pierre Fabre SA
 Pierre Fabre SA BiotechnologyHealth Technology Engages in research and preclinical development of biologics & pharmaceuticals | Health Technology |
Pierre Fabre Médicament SAS
 Pierre Fabre Médicament SAS Pharmaceuticals: OtherHealth Technology Manufactures cosmetics and pharmaceutical products | Health Technology |
Cellectis SA
 Cellectis SA Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops immunotherapies | Health Technology |
Université Paris Diderot-Paris 7
 Université Paris Diderot-Paris 7 Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Takara Bio Europe AB
 Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Develops hepatocytes and cardiomyocytes from the proprietary stem cells | Commercial Services |
Vaximm AG
 Vaximm AG Miscellaneous Commercial ServicesCommercial Services Develops immunotherapies for cancer treatment | Commercial Services |
Asarina Pharma AB
 Asarina Pharma AB Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
Messier Maris & Associés SCA
Messier Maris & Associés SCA Investment ManagersFinance Provides financial consulting and investment advisory services | Finance |
Ectycell SASU
 Ectycell SASU BiotechnologyHealth Technology Produces and sales stem cells | Health Technology |
YSOPIA Biosciences SA
 YSOPIA Biosciences SA BiotechnologyHealth Technology Develops therapeutic solutions for metabolic and cardiometabolic disorders | Health Technology |
Wyeth-Ayerst International LLC | |
Lysogene SA
 Lysogene SA BiotechnologyHealth Technology Engages in research and clinical development of gene therapy for neurodegenerative disorders | Health Technology |
Farmindustria
 Farmindustria Miscellaneous Commercial ServicesCommercial Services Operates as a healthcare organization | Commercial Services |
Idorsia Ltd.
 Idorsia Ltd. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of medicines for unmet medical needs | Health Technology |
Aileens Pharma Srl
Aileens Pharma Srl Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on biotechnology | Commercial Services |
Idorsia Pharmaceuticals Ltd.
Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceuticals | Health Technology |
Affimed GmbH
Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Provides business and private economic services | Commercial Services |
Epsilen Bio Srl
Epsilen Bio Srl Pharmaceuticals: MajorHealth Technology Develops therapies for genetic diseases | Health Technology |
Cellectis Therapeutics |
